Skip to main content
. 2021 Jun 28;22(13):6948. doi: 10.3390/ijms22136948

Figure 5.

Figure 5

pLKO.1-puro and lincRNA-p21 targeting efficacy in sh-lincRNA-21-transduced stable transfectants. (A) Map of pLKO.1-puro with a 1.9 kb stuffer removed by AgeI and EcoRI cutting, a total of 9.3 kb in length. (B) Four designed shRNA sequences targeting mouse lincRNA-p21. (C,D) Apoptotic cell ratios and lincRNA-p21 expression levels in transfectants stimulated with various concentrations of Dox for 24 h. (E) Representative lincRNA-p21 targeting efficacy in three sh-lincRNA-p21-transfected transfectants with sh-luciferase-transfected transfectant as the control under different concentrations of Dox stimulation. Relative abundance of a measured gene expression was normalized by GAPDH gene from each sample. The expression levels of alveolar epithelial cells without stimulation or control transfectants were determined as 100%. Values are mean ± SEM. All of the in-vitro results in Figure 5 were representative of at least three independent experiments with similar findings.